Free tool
Healthcare stocks
We cover 699 companies in the Healthcare sector. The median market value in the group is $90.10M. Across the group, the median move over the past trading day is −0.15%. 52% of the 681 with a 200-day average trade above it. Price change over the past year runs from −84.9% to +155.8% across the middle 80 percent of the group, with a median of −6.4%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
699 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ABTT34.SA | Abbott Laboratories | $199.23B | Large cap | −16.35% |
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% |
| GILD34.SA | Gilead Sciences, Inc. | $184.15B | Large cap | −79.11% |
| PFIZ34.SA | Pfizer Inc. | $161.53B | Large cap | +11.58% |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% |
| DHER34.SA | Danaher Corporation | $151.72B | Large cap | +0.89% |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | $139.70B | Large cap | −83.18% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +40.74% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −21.38% |
| I1SR34.SA | Intuitive Surgical, Inc. | $132.60B | Large cap | −25.36% |
| S1YK34.SA | Stryker Corporation | $126.60B | Large cap | −19.51% |
| SYK | Stryker Corporation | $126.45B | Large cap | −15.52% |
| MDTC34.SA | Medtronic plc | $118.37B | Large cap | −75.74% |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% |
| SNY | Sanofi | $108.83B | Large cap | −4.33% |
| G1SK34.SA | GSK plc | $104.64B | Large cap | +27.31% |
| M1CK34.SA | McKesson Corporation | $104.59B | Large cap | −92.49% |
| MCK | McKesson Corporation | $104.54B | Large cap | +31.57% |
| GSK | GSK plc | $104.29B | Large cap | +32.23% |
| HCA | HCA Healthcare, Inc. | $94.76B | Large cap | +5.96% |
| H1CA34.SA | HCA Healthcare, Inc. | $92.89B | Large cap | +2.99% |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% |
| E1LV34.SA | Elevance Health, Inc. | $86.53B | Large cap | +21.66% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.16B | Large cap | +33.80% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| CI | The Cigna Group | $74.22B | Large cap | −4.84% |
| C1IC34.SA | The Cigna Group | $73.39B | Large cap | −85.33% |
| B1SX34.SA | Boston Scientific Corporation | $70.04B | Large cap | −89.24% |
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −54.50% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| M1RN34.SA | Moderna, Inc. | $63.51B | Large cap | +462.13% |
| A1RG34.SA | argenx SE | $63.16B | Large cap | +36.97% |
| COR | Cencora, Inc. | $62.55B | Large cap | +13.45% |
| MRNA | Moderna, Inc. | $59.75B | Large cap | +496.25% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $57.22B | Large cap | +18.03% |
| C1AH34.SA | Cardinal Health, Inc. | $55.77B | Large cap | +52.41% |
| CAH | Cardinal Health, Inc. | $55.45B | Large cap | +61.05% |
| C1CO34.SA | Cencora, Inc. | $52.41B | Large cap | −12.17% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.21% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| B1DX34.SA | Becton, Dickinson and Company | $51.78B | Large cap | −113.87% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| E1WL34.SA | Edwards Lifesciences Corporation | $47.29B | Large cap | −4.72% |
| HUM | Humana Inc. | $46.96B | Large cap | +33.14% |
| H1UM34.SA | Humana Inc. | $46.72B | Large cap | +24.36% |
| MDLN | Medline Inc. | $46.53B | Large cap | −13.07% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| HLN | Haleon plc | $44.72B | Large cap | +6.13% |
| I1DX34.SA | IDEXX Laboratories, Inc. | $44.35B | Large cap | −17.31% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $44.24B | Large cap | +94.70% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% |
| A | Agilent Technologies, Inc. | $43.80B | Large cap | +31.46% |
| IDXX | IDEXX Laboratories, Inc. | $43.66B | Large cap | −13.64% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| V2EE34.SA | Veeva Systems Inc. | $41.01B | Large cap | −18.65% |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% |
| VEEV | Veeva Systems Inc. | $39.78B | Large cap | −16.58% |
| A1GI34.SA | Agilent Technologies, Inc. | $39.64B | Large cap | −77.37% |
| WATC34.SA | Waters Corporation | $36.35B | Large cap | +24.76% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| ALC | Alcon Inc. | $35.13B | Large cap | −10.24% |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% |
| I1LM34.SA | Illumina, Inc. | $34.10B | Large cap | +113.13% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| D1EX34.SA | DexCom, Inc. | $33.75B | Large cap | +9.64% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| C1NC34.SA | Centene Corporation | $32.65B | Large cap | +116.61% |
| BIIB34.SA | Biogen Inc. | $32.56B | Large cap | +47.86% |
| CNC | Centene Corporation | $32.34B | Large cap | +127.01% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% |
| Z1TS34.SA | Zoetis Inc. | $32.03B | Large cap | −52.31% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | −49.35% |
| B1NT34.SA | BioNTech SE | $28.32B | Large cap | +2.68% |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.81% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| R1MD34.SA | ResMed Inc. | $27.33B | Large cap | −38.24% |
| INSM | Insmed Incorporated | $27.16B | Large cap | −7.54% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | +1.27% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| I1NC34.SA | Incyte Corporation | $25.83B | Large cap | +41.91% |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% |
| STE | STERIS plc | $23.09B | Large cap | −4.41% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| S1TE34.SA | STERIS plc | $19.75B | Large cap | −18.78% |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | $18.07B | Large cap | −5.04% |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% |
| ASND | Ascendis Pharma A/S | $16.41B | Large cap | +29.66% |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +13.36% |
| N1BI34.SA | Neurocrine Biosciences, Inc. | $15.65B | Large cap | +7.37% |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% |
| C1OO34.SA | The Cooper Companies, Inc. | $15.12B | Large cap | −0.89% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.92B | Large cap | +1.37% |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −1.93% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | +3.61% |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% |
| CORT | Corcept Therapeutics Incorporated | $12.95B | Large cap | +71.81% |
| S1NN34.SA | Smith & Nephew plc | $12.87B | Large cap | −20.44% |
| PEN | Penumbra, Inc. | $12.72B | Large cap | +21.02% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | $12.54B | Large cap | +4.97% |
| ELAN | Elanco Animal Health Incorporated | $12.53B | Large cap | +35.64% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.21% |
| R1VT34.SA | Revvity, Inc. | $12.50B | Large cap | +22.81% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +26.78% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| EHC | Encompass Health Corporation | $11.92B | Large cap | −1.75% |
| DVAI34.SA | DaVita Inc. | $11.70B | Large cap | +18.80% |
| T1CH34.SA | Bio-Techne Corporation | $11.51B | Large cap | +23.42% |
| A1LG34.SA | Align Technology, Inc. | $11.51B | Large cap | +7.83% |
| DVA | DaVita Inc. | $11.41B | Large cap | +30.89% |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +156.37% |
| ALGN | Align Technology, Inc. | $11.31B | Large cap | +12.09% |
| GMED | Globus Medical, Inc. | $11.16B | Large cap | +35.10% |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% |
| AXSM | Axsome Therapeutics, Inc. | $10.85B | Large cap | +69.99% |
| I1QV34.SA | IQVIA Holdings Inc. | $10.82B | Large cap | −67.19% |
| GKOS | Glaukos Corporation | $10.65B | Large cap | +89.83% |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +143.67% |
| MOH | Molina Healthcare, Inc. | $10.57B | Large cap | +13.35% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +48.21% |
| U1HS34.SA | Universal Health Services, Inc. | $10.55B | Large cap | −6.44% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | −1.76% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −14.19% |
| ABVX | ABIVAX Société Anonyme | $10.17B | Large cap | +46.70% |
| R1DY34.SA | Dr. Reddy's Laboratories Limited | $9.95B | Mid cap | −20.54% |
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% |
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +9.93% |
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +99.97% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| ALKS | Alkermes plc | $8.25B | Mid cap | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $8.13B | Mid cap | +446.12% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +1112.03% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% |
| RADL3.SA | Raia Drogasil S.A. | $6.56B | Mid cap | +7.42% |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +196.85% |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +92.20% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% |
| BLCO.TO | Bausch + Lomb Corporation | $6.18B | Mid cap | +19.34% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.56% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.07B | Mid cap | +46.02% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% |
| DFTX | Definium Therapeutics, Inc. | $5.88B | Mid cap | +344.37% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| GRFS | Grifols, S.A. | $5.38B | Mid cap | −19.39% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +207.13% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +121.31% |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +90.31% |
| WAY | Waystar Holding Corp. | $4.63B | Mid cap | −34.97% |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% |
| MANE | Veradermics, Incorporated | $4.29B | Mid cap | +172.32% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | Mid cap | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −29.83% |
| LEGN | Legend Biotech Corporation | $4.02B | Mid cap | −40.44% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +57.50% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| TLX | Telix Pharmaceuticals Limited | $3.77B | Mid cap | −8.02% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| OPCH | Option Care Health, Inc. | $3.60B | Mid cap | −15.91% |
| A2LC34.SA | Alcon Inc. | $3.57B | Mid cap | −12.15% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +159.74% |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% |
| QURE | uniQure N.V. | $3.53B | Mid cap | +223.49% |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +11.97% |
| MBX | MBX Biosciences, Inc. | $3.22B | Mid cap | +366.53% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +79.06% |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +60.64% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.10B | Mid cap | +22.19% |
| ALMS | Alumis Inc. | $3.06B | Mid cap | +380.08% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +55.61% |
| ALHC | Alignment Healthcare, Inc. | $2.88B | Mid cap | −13.88% |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +37.81% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% |
| PRVA | Privia Health Group, Inc. | $2.71B | Mid cap | −3.13% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +67.21% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.61B | Mid cap | −0.42% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −12.10% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +15.38% |
| CURA.TO | Curaleaf Holdings, Inc. | $2.51B | Mid cap | +197.74% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% |
| PBH | Prestige Consumer Healthcare Inc. | $2.47B | Mid cap | −22.12% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% |
| BHC.TO | Bausch Health Companies Inc. | $2.43B | Mid cap | −9.88% |
| KLRA | Kailera Therapeutics, Inc. | $2.39B | Mid cap | −29.08% |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% |
| ALMR | Alamar Biosciences, Inc. | $2.36B | Mid cap | +54.91% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.30B | Mid cap | +44.68% |
| MLYS | Mineralys Therapeutics, Inc. | $2.28B | Mid cap | +70.22% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +57.99% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| XRAY | DENTSPLY SIRONA Inc. | $2.18B | Mid cap | −21.61% |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +146.56% |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% |
| ZBIO | Zenas BioPharma, Inc. | $2.15B | Mid cap | +97.73% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +70.71% |
| CLOV34.SA | Clover Health Investments, Corp. | $2.15B | Mid cap | +45.23% |
| HCM | HUTCHMED (China) Limited | $2.15B | Mid cap | −17.45% |
| STOK | Stoke Therapeutics, Inc. | $2.14B | Mid cap | +71.45% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +50.21% |
| GENB | Generate Biomedicines, Inc. | $2.07B | Mid cap | +27.59% |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +7.69% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $2.03B | Mid cap | −13.45% |
| CMPS | COMPASS Pathways plc | $2.02B | Mid cap | +209.53% |
| KLRS | Kalaris Therapeutics, Inc. | $99.98M | Micro cap | +32.47% |
| CGTX | Cognition Therapeutics, Inc. | $99.85M | Micro cap | −65.69% |
| PARK | Park Dental Partners, Inc. | $99.15M | Micro cap | +103.41% |
| FBIO | Fortress Biotech, Inc. | $94.38M | Micro cap | +20.09% |
| PLYX | Polaryx Therapeutics, Inc. | $94.21M | Micro cap | −94.03% |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% |
| ACH | Accendra Health, Inc. | $93.82M | Micro cap | −75.05% |
| ALDX | Aldeyra Therapeutics, Inc. | $93.51M | Micro cap | −73.33% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +52.94% |
| ECOR | electroCore, Inc. | $93.31M | Micro cap | +86.49% |
| HYPR | Hyperfine, Inc. | $92.06M | Micro cap | −29.99% |
| ICCC | ImmuCell Corporation | $91.00M | Micro cap | +64.26% |
| DWTX | Dogwood Therapeutics, Inc. | $90.42M | Micro cap | −42.80% |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $90.10M | Micro cap | −11.35% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| CWEB.TO | Charlotte's Web Holdings, Inc. | $88.25M | Micro cap | +253.85% |
| AALR3.SA | Alliança Saúde e Participações S.A. | $87.57M | Micro cap | −52.03% |
| CVRX | CVRx, Inc. | $87.12M | Micro cap | −56.75% |
| ATHE | Alterity Therapeutics Limited | $86.64M | Micro cap | −4.40% |
| CING | Cingulate Inc. | $85.36M | Micro cap | +29.19% |
| GOSS | Gossamer Bio, Inc. | $85.01M | Micro cap | −92.93% |
| MAIA | MAIA Biotechnology, Inc. | $84.56M | Micro cap | −15.76% |
| VRCA | Verrica Pharmaceuticals Inc. | $84.35M | Micro cap | −13.25% |
| DH | Definitive Healthcare Corp. | $84.34M | Micro cap | −80.44% |
| ACET | Adicet Bio, Inc. | $83.79M | Micro cap | −26.01% |
| RPID | Rapid Micro Biosystems, Inc. | $83.77M | Micro cap | −34.77% |
| CTOR | Citius Oncology, Inc. | $83.24M | Micro cap | −62.34% |
| GANX | Gain Therapeutics, Inc. | $83.14M | Micro cap | −2.69% |
| SERA | Sera Prognostics, Inc. | $82.45M | Micro cap | −26.41% |
| HLS.TO | HLS Therapeutics Inc. | $81.35M | Micro cap | −30.48% |
| OKYO | OKYO Pharma Limited | $81.34M | Micro cap | −31.42% |
| TELO | Telomir Pharmaceuticals, Inc. | $80.47M | Micro cap | −20.95% |
| OM | Outset Medical, Inc. | $79.89M | Micro cap | −69.56% |
| TENX | Tenax Therapeutics, Inc. | $79.34M | Micro cap | −64.19% |
| ELTX | Elicio Therapeutics, Inc. | $78.32M | Micro cap | −71.29% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +320.55% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −34.00% |
| CRDF | Cardiff Oncology, Inc. | $76.56M | Micro cap | −54.65% |
| ANVS | Annovis Bio, Inc. | $75.84M | Micro cap | −24.26% |
| LONA | LeonaBio, Inc. | $75.47M | Micro cap | +95.25% |
| NRXS | NeurAxis, Inc. | $74.84M | Micro cap | +146.28% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −31.36% |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% |
| MDXH | MDxHealth SA | $72.15M | Micro cap | −84.51% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +131.74% |
| SPRO | Spero Therapeutics, Inc. | $71.05M | Micro cap | −38.38% |
| IBIO | iBio, Inc. | $71.04M | Micro cap | +76.54% |
| ZTEK | Zentek Ltd. | $70.91M | Micro cap | −17.65% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −33.62% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| EXOZ | eXoZymes, Inc. | $69.89M | Micro cap | −22.42% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| RNTX | Rein Therapeutics Inc. | $69.01M | Micro cap | −27.27% |
| DRIO | DarioHealth Corp. | $68.89M | Micro cap | −26.92% |
| NNOX | Nano-X Imaging Ltd. | $68.83M | Micro cap | −77.77% |
| CSBR | Champions Oncology, Inc. | $68.36M | Micro cap | −25.45% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| HYFT | MindWalk Holdings Corp. | $67.19M | Micro cap | −46.04% |
| SER | Serina Therapeutics, Inc. | $66.80M | Micro cap | −47.29% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| TLPH | Talphera, Inc. | $65.40M | Micro cap | +133.33% |
| IMA | ImageneBio, Inc. | $61.64M | Micro cap | −60.19% |
| MYO | Myomo, Inc. | $60.60M | Micro cap | +36.61% |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | $60.44M | Micro cap | +29.47% |
| INKT | MiNK Therapeutics, Inc. | $60.16M | Micro cap | −26.22% |
| XLO | Xilio Therapeutics, Inc. | $59.55M | Micro cap | −5.63% |
| HRTX | Heron Therapeutics, Inc. | $59.27M | Micro cap | −77.04% |
| DXR | Daxor Corporation | $58.53M | Micro cap | −11.60% |
| COCH | Envoy Medical, Inc. | $56.82M | Micro cap | −37.09% |
| SCYX | SCYNEXIS, Inc. | $56.41M | Micro cap | +579.04% |
| IMMP | Immutep Limited | $56.00M | Micro cap | −77.11% |
| NTRB | Nutriband Inc. | $54.70M | Micro cap | −29.80% |
| GNTA | Genenta Science S.p.A. | $54.49M | Micro cap | −70.07% |
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| SRTS | Sensus Healthcare, Inc. | $54.16M | Micro cap | +3.46% |
| ATYR | aTyr Pharma, Inc. | $54.05M | Micro cap | −89.34% |
| TIL | Instil Bio, Inc. | $53.10M | Micro cap | −72.04% |
| TELY.TO | TelyRx Holdings Inc. | $52.69M | Micro cap | −21.43% |
| HYPD | Hyperion DeFi, Inc. | $52.68M | Micro cap | −50.87% |
| BTMD | biote Corp. | $52.54M | Micro cap | −53.87% |
| MDAI | Spectral AI, Inc. | $51.82M | Micro cap | −23.33% |
| TCRX | TScan Therapeutics, Inc. | $50.80M | Micro cap | −58.43% |
| IBO | Impact BioMedical Inc. | $49.62M | Micro cap | −24.12% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| NSRX | Nasus Pharma Ltd. | $48.01M | Micro cap | −49.75% |
| MLSS | Milestone Scientific Inc. | $47.87M | Micro cap | −10.10% |
| MCRB | Seres Therapeutics, Inc. | $47.81M | Micro cap | −74.79% |
| EDSA | Edesa Biotech, Inc. | $47.63M | Micro cap | +105.83% |
| POCI | Precision Optics Corporation, Inc. | $47.61M | Micro cap | −12.30% |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −33.72% |
| QTI | QT Imaging Holdings, Inc. | $46.40M | Micro cap | −91.44% |
| GRCE | Grace Therapeutics, Inc. | $46.28M | Micro cap | −29.97% |
| MGX | Metagenomi Therapeutics, Inc. | $46.09M | Micro cap | −34.41% |
| FLNA | Filana Therapeutics, Inc. | $45.83M | Micro cap | −59.98% |
| AIAI.TO | NetraMark Holdings Inc. | $45.68M | Micro cap | −60.82% |
| XTNT | Xtant Medical Holdings, Inc. | $45.03M | Micro cap | −47.38% |
| IXHL | Incannex Healthcare Inc. | $44.87M | Micro cap | −81.59% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $44.46M | Micro cap | −74.90% |
| MREO | Mereo BioPharma Group plc | $44.39M | Micro cap | −84.20% |
| ELUT | Elutia Inc. | $44.29M | Micro cap | −54.75% |
| NEPH | Nephros, Inc. | $43.98M | Micro cap | 0.00% |
| TVGN | Tevogen Inc. | $43.63M | Micro cap | −85.43% |
| PAVM | PAVmed Inc. | $42.54M | Micro cap | −63.21% |
| VVEO3.SA | CM Hospitalar S/A | $42.35M | Micro cap | −24.72% |
| SNWV | SANUWAVE Health, Inc. | $41.89M | Micro cap | −89.02% |
| NSPR | InspireMD, Inc. | $41.69M | Micro cap | −63.52% |
| CRVO | CervoMed Inc. | $40.07M | Micro cap | −71.78% |
| CNTX | Context Therapeutics Inc. | $40.00M | Micro cap | −50.73% |
| DCGO | DocGo Inc. | $39.10M | Micro cap | −75.60% |
| PETS | PetMed Express, Inc. | $38.81M | Micro cap | −43.35% |
| CPHI | China Pharma Holdings, Inc. | $38.68M | Micro cap | −35.78% |
| BDMD | Baird Medical Investment Holdings Limited | $37.74M | Micro cap | −52.03% |
| BCT.TO | BriaCell Therapeutics Corp. | $35.23M | Micro cap | −46.48% |
| BCTX | BriaCell Therapeutics Corp. | $35.06M | Micro cap | −46.97% |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% |
| CCEL | Cryo-Cell International, Inc. | $34.67M | Micro cap | −3.19% |
| LITS | Lite Strategy, Inc. | $33.79M | Micro cap | −80.75% |
| ONMD | OneMedNet Corporation | $33.70M | Micro cap | −30.33% |
| NSYS | Nortech Systems Incorporated | $33.62M | Micro cap | +30.74% |
| YI | 111, Inc. | $32.90M | Micro cap | −46.57% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| NNVC | NanoViricides, Inc. | $32.68M | Micro cap | −9.86% |
| RMTI | Rockwell Medical, Inc. | $31.90M | Micro cap | +438.44% |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% |
| ESLA | Estrella Immunopharma, Inc. | $31.75M | Micro cap | −22.34% |
| ATNM | Actinium Pharmaceuticals, Inc. | $31.69M | Micro cap | −42.61% |
| ARAY | Accuray Incorporated | $31.57M | Micro cap | −83.17% |
| MIRA | MIRA Pharmaceuticals, Inc. | $31.52M | Micro cap | −45.26% |
| IGC | IGC Pharma, Inc. | $31.49M | Micro cap | −31.62% |
| MDNA.TO | Medicenna Therapeutics Corp. | $31.26M | Micro cap | −56.48% |
| TELA | TELA Bio, Inc. | $31.03M | Micro cap | −60.73% |
| MBX.TO | Microbix Biosystems Inc. | $30.10M | Micro cap | +27.08% |
| SVA.TO | Sernova Biotherapeutics Inc | $29.93M | Micro cap | −42.11% |
| BALM4.SA | Baumer S.A. | $29.30M | Micro cap | +22.57% |
| BRNS | Barinthus Biotherapeutics plc | $28.86M | Micro cap | −38.04% |
| GRDX | GridAI Technologies Corp. | $28.75M | Micro cap | +111.52% |
| BYSI | BeyondSpring Inc. | $28.37M | Micro cap | −62.09% |
| CVM | CEL-SCI Corporation | $28.32M | Micro cap | −87.65% |
| OPTH | Optimi Health Corp. | $28.06M | Micro cap | −19.41% |
| LTRN | Lantern Pharma Inc. | $27.87M | Micro cap | −46.17% |
| BEAT | HeartBeam, Inc. | $27.13M | Micro cap | −59.20% |
| NXTC | NextCure, Inc. | $27.05M | Micro cap | +11.37% |
| EVAX | Evaxion A/S | $27.02M | Micro cap | +6.93% |
| MODD | Modular Medical, Inc. | $26.98M | Micro cap | −85.11% |
| PSTV | Plus Therapeutics Inc | $26.64M | Micro cap | −68.67% |
| ENLV | Enlivex Ltd. | $26.58M | Micro cap | +38.99% |
| DYAI | Dyadic International, Inc. | $26.45M | Micro cap | −29.02% |
| ATOS | Atossa Therapeutics, Inc. | $26.45M | Micro cap | −76.75% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| RVX.TO | Resverlogix Corp. | $24.81M | Micro cap | 0.00% |
| MRKR | Marker Therapeutics, Inc. | $24.18M | Micro cap | +54.26% |
| CLRB | Cellectar Biosciences, Inc. | $24.01M | Micro cap | −47.30% |
| JSPR | Jasper Therapeutics, Inc. | $23.96M | Micro cap | −75.24% |
| FEMY | Femasys Inc. | $23.87M | Micro cap | +711.11% |
| TVRD | Tvardi Therapeutics, Inc. | $23.74M | Micro cap | −94.18% |
| BTAI | BioXcel Therapeutics, Inc. | $23.23M | Micro cap | −80.30% |
| LABS.TO | MediPharm Labs Corp. | $23.16M | Micro cap | +6.67% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| CTSO | Cytosorbents Corporation | $22.62M | Micro cap | −61.29% |
| RVP | Retractable Technologies, Inc. | $21.85M | Micro cap | −12.05% |
| PLRZ | Polyrizon Ltd. | $21.83M | Micro cap | +85.08% |
| LGVN | Longeveron Inc. | $21.68M | Micro cap | −14.44% |
| COCP | Cocrystal Pharma, Inc. | $21.57M | Micro cap | −27.74% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.